ATCC, a non-profit organization founded in 1925, is the world’s most diverse biological resource center, supporting public health initiatives for the US government, academia, the pharmaceutical industry, and research foundations.
For more than 50 years, we have supported federal agencies through contracts focused on global health and infectious diseases, biodefense, chronic diseases, clinical study support, global logistics, and biorepository establishment/maintenance - all combined with our commitment to quality and responsive management. ATCC provides federal agencies with curated, high quality biomaterials and resources, laboratory services, and repository operations.
Biodefense and Emerging Infections Resources
Biodefense and Emerging Infections (BEI) Resources was established by the National Institute of Allergy and Infectious Diseases (NIAID) to provide reagents, tools and information for studying Category A, B, and C priority pathogens, emerging infectious disease agents, non-pathogenic microbes and other microbiological materials of relevance to the research community.Get details
International Reagent Resource
The International Reagent Resource (IRR) was established by the Centers for Disease Control and Prevention (CDC) to provide registered users with reagents, test kits, and information for the study and detection of emerging bacterial and viral pathogens, as well as outbreak response.Get details
HIV Reagent Program
The NIH HIV Reagent Program was established in 1988 to provide critical research reagents and resources to the scientific community. The NIH HIV Reagent Program acquires, develops and produces state-of-the-art reagents and provides these reagents at no cost to qualified investigators throughout the world.Get details
Providing support to the federal government for over 50 years
Biological Resource Support
ATCC operates and manages biological resource programs, including new product development, accessions, production, authentication, storage, and distribution.Learn about our expertise
Clinical Study Support
ATCC provides clinical and epidemiological study support to include provision of collection supplies, sample receipt and storage, biospecimen processing, and distribution.explore now
Featured blog posts
Replenishment of the Adenovirus Reference Material
February 21, 2024
Get the details on how the reference material was developed at ATCC.Read the blog post
ATCC Federal Solutions (AFS) Fuels Global Malaria Fight
October 25, 2023
Learn how AFS is accelerating the development of malaria diagnostics and interventions.Read the blog post
Featured news releases
ATCC Announces New Award from BARDA to Provide Centralized Storage and Bioprocessing Services for Project NextGen
ATCC announced a 5-year, $87 million award from BARDA to support the development of next-generation medical countermeasures.
ATCC announced a seven-year contract, with an initial award of over $21.5 million, from NIAID to continue the management of the newly merged NIH HIV Reagent Program with the BEI Resources Program.
ATCC Announces Comprehensive and Rapid Response to NIAID Research Programs (CARRRP) Award from NIAID
ATCC was awarded a Task Order under the Comprehensive and Rapid Response to NIAID Research Programs (CARRRP) to manage critical biomaterials for NIAID's Vaccine Research Center.
ATCC catalog item MSA-2003-ISS was sent to the International Space Station (ISS National Lab) aboard the SpaceX CRS-29 mission.
ATCC Federal Solutions Leadership
Joseph Leonelli, PhD
Senior Vice President, ATCC Federal Solutions (AFS)
Joe is the Senior Vice President of ATCC Federal Solutions (AFS). He is responsible for the overall strategy, management and growth of AFS programs, which include products and services for emerging infectious disease, biodefense, medical countermeasures, and global health security.
Rebecca Bradford, MBA, MS, PMP
Vice President, Government Programs, ATCC Federal Solutions (AFS)
Rebecca is responsible for the AFS business growth strategy, improved program management, and corporate responsiveness to the government and research community needs. Rebecca manages a portfolio of programs with NIAID, CDC, and BARDA that provide products and services to help the government address emerging infectious diseases, pandemic response and preparedness, medical countermeasures, and global health security.
Ted Mullins, PhD
Senior Director of Business Development, ATCC Federal Solutions (AFS)
Ted is the Senior Director of Business Development for AFS and the Responsible Official for the ATCC Federal Select Agent Program. During his 21 years at ATCC, he has served in positions ranging from the Director of Bioproduction to Program Manager for NIAID, CDC, and USDA contracts focusing on biological resource management and biodefense.
Sujatha Rashid, PhD, PMP
Director, Government Programs, ATCC Federal Solutions (AFS)
Sujatha is a Director of Government Programs at ATCC and is responsible for managing a portfolio of NIAID programs including BEI Resources and the HIV Reagent Program. She is a subject matter expert in medical and clinical virology. Sujatha has been with AFS since 2008 and is responsible for providing scientific leadership for emerging infectious diseases and pandemic response and preparedness.
Carla Williams Smith
Director, Contracts, ATCC Federal Solutions (AFS)
Carla is a Director of Contracts for ATCC Federal Solutions and is responsible for managing all contractual, financial and administrative aspects of ATCC’s federal programs. Carla is an expert in the contract and proposal process and ensures ATCC adheres to all laws, regulations, and policies.
ATCC Greenhouse Gas Emissions ReportRead our report
ATCC Corporate Policy – Federal Awards Conflict Of InterestRead our policy
Contact ATCC Federal Solutions
Thank you for your interest in ATCC Federal Solutions. Please fill out the form and let us help you meet your goals.